Results 81 to 90 of about 118,635,816 (237)

Symptoms, Diagnosis, and Treatment for Women and Girls With Hemophilia: A Narrative Review

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Hemophilia is an X‐linked bleeding disorder previously thought to present only in men. This sentiment is rapidly changing as the information around women and girls’ experiences of bleeding symptoms has evolved, sparking intense discussion among researchers, clinicians, patients, and patient advocates regarding appropriate ...
Sam Hirniak   +6 more
wiley   +1 more source

Coexistence of Acquired Hemophilia and Antiphospholipid Serology in Monoclonal Gammopathy Patient

open access: yesInternational Medical Case Reports Journal, 2021
Nabil Belfeki, Sarra Hamrouni, Alessio Strazzulla, Sylvain Diamantis Department of Internal Medicine, Groupe Hospitalier Sud-Ile de France, Melun, 77000, FranceCorrespondence: Nabil BelfekiDepartment of Internal Medicine, Groupe Hospitalier Sud Ile de ...
Belfeki N   +3 more
doaj  

Population‐Level Real‐World Healthcare Costs in Men and Women With Haemophilia A

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Even with modern prophylaxis options, people living with haemophilia have significantly lower quality of life and joint health outcomes than those without. Aim Our goal was to determine if real‐world health‐system costs are higher for people living with haemophilia A compared to those without and determine how joint‐health state ...
Sam Hirniak   +6 more
wiley   +1 more source

Acquired Hemophilia in a Woman

open access: yesEurasian Journal of Medicine, 2019
-
Özden Vural   +3 more
doaj  

Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study

open access: yes
Haemophilia, EarlyView.
Erin Cockrell   +18 more
wiley   +1 more source

Changes in Hypertrophic Synovium Status in Adult Patients With Severe Hemophilia A Receiving Emicizumab Prophylaxis: The RESOLVE Study

open access: yesHaemophilia, EarlyView.
ABSTRACT Background Evidence on the impact of emicizumab on joint health, particularly hypertrophic synovium (HS), remains limited. Objectives To evaluate changes in HS, using point‐of‐care ultrasound and clinical examination in People with Haemophilia (PwH) switching from replacement therapy to emicizumab.
Matteo Nicola Dario Di Minno   +8 more
wiley   +1 more source

Acquired Hemophilia in a Patient with Rheumatoid Arthritis

open access: yes, 2010
Acquired hemophilia is a rare disease caused by an autoimmune reaction to coagulation factor VIII, The mortality rate of this disease is very high (8 22%). Clinical manifestations are different from congenital hemophilia.
���������
core  

Artificial Intelligence and Machine Learning in the Context of Hemophilia: A Scope Review

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Advances in hemophilia treatment have improved life expectancy, yet challenges remain in disease management, predicting clinical complications, and optimizing healthcare resources. Artificial intelligence (AI) and machine learning (ML) have emerged as promising tools to support clinical decision‐making and personalized care ...
Tatyane Oliveira Rebouças   +4 more
wiley   +1 more source

Acute Atraumatic Compartment Syndrome of the Hand Due to Acquired Hemophilia A

open access: yesJournal of Hand Surgery Global Online, 2019
Acquired hemophilia A (factor VIII inhibitor) is a rare idiopathic disease with a high rate of morbidity and mortality. We report the case of an 83-year-old woman who presented with atraumatic compartment syndrome of the right hand resulting from ...
Daniel Walder, MD   +4 more
doaj   +1 more source

Acquired hemophilia.

open access: yesHaematologica, 1995
Acquired hemophilia is a very rare disease characterized by the presence of an autoantibody (mainly IgG) to factor VIII, with a clinical presentation resembling hemophilia A. It is associated with various autoimmune or dermatologic diseases, pregnancy, cancer, or drug ingestion, but in almost 50% of patients no underlying disorder is found.
P, Bouvry, P, Recloux
openaire   +1 more source

Home - About - Disclaimer - Privacy